Modification 00001: clarification of shelf-life dating
Ended Awarded Last action
- Contract number
- HHSD2002014602890006
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $49,999,746
Award facts
- Contract value 100% obligated
- $49,999,745.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- CDC Pittsburgh Centers for Disease Control and Prevention, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Transfer Action | $0 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | -$8 | |
| Original award | $49,999,753 |
About this award
This is a modification to a $49,999,745.68 firm fixed price delivery order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Glaxosmithkline, LLC. The contract is for the provision of pharmaceutical products including vaccines, antiviral medications, and vaccine adjuvants to support various U.S. government agencies. The contract has no set-aside designation. Glaxosmithkline has a history of providing a range of pharmaceutical products and services as a prime contractor on federal contracts, supporting disease prevention efforts, immunization programs, drug stockpiling initiatives, and correctional healthcare services. The company also serves as a subcontractor on a large Department of Defense contract for COVID-19 monoclonal antibody therapeutics distribution and logistics. Glaxosmithkline additionally holds several federal contract indefinite delivery vehicles for the supply of seasonal influenza vaccines, vaccine storage and rotation services, and the antiviral medication zanamivir.
Quick answers
Who was awarded contract HHSD2002014602890006?
HHSD2002014602890006 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 20, 2017.
How much is contract HHSD2002014602890006 worth?
The government has obligated $49,999,746 on HHSD2002014602890006.
Which agency awarded contract HHSD2002014602890006?
Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) awarded HHSD2002014602890006, with funding from CDC Pittsburgh (Centers for Disease Control and Prevention).
Is contract HHSD2002014602890006 an order under another contract?
Yes. HHSD2002014602890006 is a delivery order under HHSD200201460289I, an indefinite delivery contract.
Was contract HHSD2002014602890006 competed?
The extent of competition for HHSD2002014602890006 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award